文献速递细胞病理与分子病理

COVID-19封锁后意大利细胞病理学实践变化

Cytopathology practice during the COVID-19 postlockdown: An Italian experience.
PubMed 文献 · Cancer Cytopathol · 2021-02-17

该研究比较了意大利那不勒斯费德里科二世大学在封锁后12周与2019年同期细胞学样本类型百分比及恶性诊断率。结论认为工作量减少是疫情持续影响,而恶性率上升反映优先处理高肿瘤风险患者的诊断程序的重要性。

要点

  • 封锁后12周总体细胞学工作量较2019年同期下降41.6%。
  • 各样本类型工作量均下降,唾液腺降61%、甲状腺降54.5%、乳腺降43%等。

核心结论

  • 封锁后细胞学工作量减少是COVID-19疫情的持续影响。
  • 总体恶性率上升反映优先处理高肿瘤风险患者诊断程序的重要性。

研究设计与样本

  • 比较意大利那不勒斯费德里科二世大学封锁后前12周与2019年同期细胞学样本类型百分比。
  • 研究期分为四个3周时段,并评估恶性诊断率差异。

主要发现

  • 12周内总体细胞学样本工作量较2019年下降41.6%。
  • 各样本类型工作量显著下降:Pap涂片-33.3%、尿液-42.8%、浆液-14.4%、甲状腺-54.5%、乳腺-43%、淋巴结-27.3%、唾液腺-61%。
  • 总体恶性率显著增加(P = .0011)。

临床怎么用

  • 疫情后恢复期应优先安排高肿瘤风险患者的细胞学诊断程序。
  • 需关注细胞学工作量下降可能延误低风险筛查,但恶性率上升提示诊断资源应集中于高风险人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: During the current coronavirus disease 2019 (COVID-19) pandemic, the cytopathology workload has decreased remarkably worldwide as all screening and elective procedures have been postponed to prioritize the clinical management of patients at high oncological risk. In the current study, the authors provide data on the lasting impact of COVID-19 on cytopathology practice during the initial phases of the Italian postlockdown period. METHODS: The percentages of the cytological sample types processed at the University of Naples Federico II during the first 12 weeks of the Italian postlockdown period were compared with those of the same period in 2019. The study period was divided into four 3-week periods. Differences in the rates of malignant diagnoses were also assessed. RESULTS: During the 12-week study period, the overall cytological sample workload decreased by 41.6% in comparison with 2019. In particular, the workload significantly declined for each sample type: Pap smears, -33.3%; urine, -42.8%; serous fluids, -14.4%; thyroid, -54.5%; breast, -43%; lymph node, -27.3%; and salivary gland, -61%. By contrast, the overall malignancy rate was significantly increased (P = .0011). CONCLUSIONS: The reduction in the cytological sample workload during the postlockdown period still represents an ongoing effect of the COVID-19 pandemic. On the other hand, the rise in the overall malignancy rate reflects the importance of prioritizing diagnostic procedures for patients at high oncological risk.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Vigliar E, Cepurnaite R, Iaccarino A, et al. Cytopathology practice during the COVID-19 postlockdown: An Italian experience. Cancer Cytopathol. 2021. PMID: 33595924. doi:10.1002/cncy.22416

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。